English Polski
Vol 16, No 2 (2021)
Review paper
Published online: 2021-04-30

open access

Page views 771
Article views/downloads 446
Get Citation

Connect on Social Media

Connect on Social Media

The importance of early diagnosis and treatment of obstructive sleep apnoea in patients with cardiovascular diseases

Karol Osłowski1, Wojciech Kukwa2, Daniel Śliż1
Folia Cardiologica 2021;16(2):91-96.


Obstructive sleep apnoea (OSA) is one of the most common sleep-related breathing disorders. New epidemiological studies show that the disease is much more prevalent in the general population than previously believed. Individuals with cardiovascular diseases are a special group of patients suffering from OSA as the prevalence of the disorder among them is much greater than in the general population, and it can constitute an isolated risk factor for the development of some cardiovascular diseases. This article will discuss methods for diagnosing OSA, its epidemiology among patients with particular cardiovascular diseases and the prospects for the development of screening examinations.

Article available in PDF format

View PDF Download PDF file


  1. Lee-Chiong Jr Tl. Sleep medicine: essentials and review. Oxford University Press. : Oxford.
  2. Kapur VK, Auckley DH, Chowdhuri S, et al. Clinical Practice Guideline for Diagnostic Testing for Adult Obstructive Sleep Apnea: An American Academy of Sleep Medicine Clinical Practice Guideline. J Clin Sleep Med. 2017; 13(3): 479–504.
  3. Senaratna C, Perret J, Lodge C, et al. Prevalence of obstructive sleep apnea in the general population: A systematic review. Sleep Medicine Reviews. 2017; 34: 70–81.
  4. Franklin KA, Lindberg E. Obstructive sleep apnea is a common disorder in the population-a review on the epidemiology of sleep apnea. J Thorac Dis. 2015; 7(8): 1311–1322.
  5. Heinzer R, Vat S, Marques-Vidal P, et al. Prevalence of sleep-disordered breathing in the general population: the HypnoLaus study. Lancet Respir Med. 2015; 3(4): 310–318.
  6. Khattak HK, Hayat F, Pamboukian SV, et al. Obstructive Sleep Apnea in Heart Failure: Review of Prevalence, Treatment with Continuous Positive Airway Pressure, and Prognosis. Tex Heart Inst J. 2018; 45(3): 151–161.
  7. Peppard PE, Young T, Palta M, et al. Prospective study of the association between sleep-disordered breathing and hypertension. N Engl J Med. 2000; 342(19): 1378–1384.
  8. Patel N, Donahue C, Shenoy A, et al. Obstructive sleep apnea and arrhythmia: A systemic review. Int J Cardiol. 2017; 228: 967–970.
  9. Muraki I, Wada H, Tanigawa T. Sleep apnea and type 2 diabetes. J Diabetes Investig. 2018; 9(5): 991–997.
  10. Voulgaris A, Marrone O, Bonsignore MR, et al. Chronic kidney disease in patients with obstructive sleep apnea. A narrative review. Sleep Med Rev. 2019; 47: 74–89.
  11. Truong KK, Guilleminault C. Sleep disordered breathing in pregnant women: maternal and fetal risk, treatment considerations, and future perspectives. Expert Rev Respir Med. 2018; 12(3): 177–189.
  12. Zakrzewska-Pniewska B, Kwieciński H. Powikłania neurologiczne u chorych na OBPS. Pneumonol Alergol Pol 2007;75. 2007; 75(Suppl 1): 62–64.
  13. Patinkin ZW, Feinn R, Santos M. Metabolic consequences of obstructive sleep apnea in adolescents with obesity: a systematic literature review and meta-analysis. Child Obes. 2017; 13(2): 102–110.
  14. Kellesarian SV, Malignaggi VR, Feng C, et al. Association between obstructive sleep apnea and erectile dysfunction: a systematic review and meta-analysis. Int J Impot Res. 2018; 30(3): 129–140.
  15. Siedlecka J, Rybacki M, Pływaczewski R, et al. [The management of obstructive sleep apnea syndrome in drivers - recommendations of the Polish Society Of Occupational Medicine, The Polish Respiratory Society, The Nofer Institute of Occupational Medicine in Lodz and The Polish Sleep Research Society]. Med Pr. 2020; 71(2): 233–243.
  16. Rosen IM, Kirsch DB, Carden KA, et al. American Academy of Sleep Medicine Board of Directors, American Academy of Sleep Medicine Board of Directors, American Academy of Sleep Medicine Board of Directors. Clinical use of a home sleep apnea test: an American Academy of Sleep Medicine Position Statement. J Clin Sleep Med. 2017; 13(10): 1205–1207, doi: 10.5664/jcsm. 6774, indexed in Pubmed. ; 28942762.
  17. Jonas DE, Amick HR, Feltner C, et al. Screening for Obstructive Sleep Apnea in Adults: Evidence Report and Systematic Review for the US Preventive Services Task Force. JAMA. 2017; 317(4): 415–433.
  18. Clinical guidelines for the use of unattended portable monitors in the diagnosis of obstructive sleep apnea in adult patients. J Clin Sleep Med. 2007; 3(7): 737–747.
  19. Mann EA, Nandkumar S, Addy N, et al. Study design considerations for sleep-disordered breathing devices. J Clin Sleep Med. 2020; 16(3): 441–449.
  20. Marin JM, Carrizo SJ, Vicente E, et al. Long-term cardiovascular outcomes in men with obstructive sleep apnoea-hypopnoea with or without treatment with continuous positive airway pressure: an observational study. Lancet. 2005; 365(9464): 1046–1053.
  21. Javaheri S, Barbe F, Campos-Rodriguez F, et al. Sleep apnea: types, mechanisms, and clinical cardiovascular consequences. J Am Coll Cardiol. 2017; 69(7): 841–858.
  22. Wolk R, Kara T, Somers VK. Sleep-disordered breathing and cardiovascular disease. Circulation. 2003; 108(1): 9–12.
  23. Huang Z, Zheng Z, Luo Y, et al. Prevalence of sleep-disordered breathing in acute coronary syndrome: a systemic review and meta-analysis. Sleep Breath. 2017; 21(1): 217–226.
  24. Jia S, Zhou YJ, Yu Yi, et al. Obstructive sleep apnea is associated with severity and long-term prognosis of acute coronary syndrome. J Geriatr Cardiol. 2018; 15(2): 146–152.
  25. Koo CY, Aung AT, Chen Z, et al. Sleep apnoea and cardiovascular outcomes after coronary artery bypass grafting. Heart. 2020; 106(19): 1495–1502.
  26. Wang X, Zhang Y, Dong Z, et al. Effect of continuous positive airway pressure on long-term cardiovascular outcomes in patients with coronary artery disease and obstructive sleep apnea: a systematic review and meta-analysis. Respir Res. 2018; 19(1): 61.
  27. Randerath W, Bonsignore MR, Herkenrath S. Obstructive sleep apnoea in acute coronary syndrome. Eur Respir Rev. 2019; 28(153).
  28. McEvoy RD, Antic NA, Heeley E, et al. SAVE Investigators and Coordinators. CPAP for prevention of cardiovascular events in obstructive sleep apnea. N Engl J Med. 2016; 375(10): 919–931.
  29. Fein AS, Shvilkin A, Shah D, et al. Treatment of obstructive sleep apnea reduces the risk of atrial fibrillation recurrence after catheter ablation. J Am Coll Cardiol. 2013; 62(4): 300–305.
  30. Qureshi WT, Nasir UB, Alqalyoobi S, et al. Meta-Analysis of continuous positive airway pressure as a therapy of atrial fibrillation in obstructive sleep apnea. Am J Cardiol. 2015; 116(11): 1767–1773.
  31. Kirchhof P, Benussi S, Kotecha D, et al. ESC Scientific Document Group. 2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS. Eur Heart J. 2016; 37(38): 2893–2962.
  32. Garrigue S, Pépin JL, Defaye P, et al. High prevalence of sleep apnea syndrome in patients with long-term pacing: the European Multicenter Polysomnographic Study. Circulation. 2007; 115(13): 1703–1709.
  33. Corral J, Mogollon MV, Sánchez-Quiroga MÁ, et al. Spanish Sleep Network. Conventional polysomnography is not necessary for the management of most patients with suspected obstructive sleep apnea. Noninferiority, randomized controlled trial. Am J Respir Crit Care Med. 2017; 196(9): 1181–1190.
  34. Mlynczak M, Migacz E, Migacz M, et al. Detecting Breathing and Snoring Episodes Using a Wireless Tracheal Sensor-A Feasibility Study. IEEE J Biomed Health Inform. 2017; 21(6): 1504–1510.